Empowering Affirming Care: Enhancing Cervical and Anal Cancer Screening for LGBTQIA+ Individuals
Lauren Abern, MD
Many lesbian, gay, bisexual, transgender, queer, intersex, asexual (LGBTQIA+) people face barriers to care that can limit their ability to access screening for HPV related cancers. Educational interventions for both healthcare providers and patients are needed to ensure screening and appropriate follow-up are performed for this community. In this session we will focus on improving cervical and anal cancer screening in the LGBTQIA+ population.
The critical role of colposcopy in cervical cancer elimination goals: Creative strategies for challenging setting
Julia Gage, PhD, MPH
While screen-and-treat strategies have been demonstrated to reduce cancer risk in settings with limited colposcopy resources, colposcopy will remain critical for cancer control in individuals not eligible with ablative therapy. This session will explore the use of strategies for improving access to colposcopy services in limited resource settings in the US and the global south.
Ten Tips for Improving the Patient Experience during Colposcopy
Patty Cason, MS, FNP-BC
Evaluation and management of cervical disease is (at best) stressful and uncomfortable for the patient. This talk provides patient-centered tips for applying principles of Trauma Informed Care that are designed to minimize pain and anxiety and improve the patient’s experience during colposcopic evaluations.
Genitourinary Syndrome of Menopause (GSM)
Peter Schnatz, DO, MBA, FACOG, FACP, NCMP
Objectives:
1. Define & discuss the signs / sx of genitourinary syndrome of menopause (GSM)
2. Review the prevalence of GSM & the impact on post-menopausal sexual health
3. Review the Vaginal Microbiome and its impact on GSM, vaginal health, & HPV
4. Review nonpharmacologic and pharmacologic treatment options for GSM
LGBTQIA+ Competence: Health Disparities Drive Anogenital Disease
John Stanton, DNP, MPH, AGPCNP-BC, AAHIVS
The omission of LGBTQIA+ content in clinical education leaves persons who identify as sexually or gender diverse (SGD) with poorer health across the lifespan. Educational interventions paired with clinical immersions in LGBTQIA+ health can improve health equity for SGD persons. This session will examine one model which showed a 62% improvement in LGBTQIA+ competency in order to help those providing anogenital care understand and ameliorate the shortfall in current clinical education.
Diagnosis and Management of Cervical Squamous Intraepithelial Lesions in Pregnancy and Postpartum
Margaret Long, MD
While pregnancy and postpartum care provide an important opportunity for cervical cancer screening and follow up of lesions, aspects of abnormal result management require adjustment during this unique time. We will focus on how management strategies differ from those outside of pregnancy, the rationales for these and some clinical pearls.
Introduce Current Situation of the Cervical Cancer Screening, Colposcopy Training, HPV Vaccination, Perianal and Valvular Lesions, and HPV Infection and Vaginal Microetiology in China
Moderator: Chengquan Zhao, MD
|
Difficulties and strategies of cervical cancer screening in China
Lihui Wei , MD
|
Research and progress in the diagnosis and treatment of perianal precancerous lesions in China
Long Sui, MD, PhD
|
Colposcopy Training and Science Education of Cervical Cancer Prevention in China
Yun Zhao, MD, PhD
|
|
Progress of the diagnosis and treatment for vulvovaginal diseases in China
Qing Cong, MD, PhD
|
Current status and progress of HPV vaccine application in China
Mingzhu Li, MD, PhD
|
HPV infection and vaginal microecology, past, current, and future in China
Pengming Sun, MD, PhD
|
The Screening and Treatment of Cervical Cancers and other HPV-Related Diseases in Indonesia
Moderators: Joe Ng, MD and Dr Brahmana Askandar, President of the Indonesian Society of Gyn Oncology, INASGO
Join us on this hour-long online educational session on cervical cancer prevention, where we will be taking a closer look at the Indonesian experience. Indonesia, like many developing countries, faces unique challenges in the fight against cervical cancer, challenges that are echoed across the globe in regions with limited resources. Despite significant progress in some areas, barriers such as access to screening, healthcare infrastructure, and public awareness continue to hinder efforts towards cervical cancer elimination. In this session, we will explore the specific hurdles Indonesia faces, discuss successful strategies that have shown promise in overcoming these obstacles, and hear directly from experts on the ground. Finally, we will focus on Indonesia’s “wishlist” for collaboration with developed countries, outlining the essential support and resources needed to accelerate the global movement toward cervical cancer elimination.
(Each for 10 minutes)
Cervical Cancer in Indonesia: Current Status, Challenges, and the Way Forward
Speaker: Brahmana Askandar, MD, PhD
Integration of HPV Vaccination into the National Immunization Program: Achievements and Challenges
Speaker: Tofan Widya Utami, MD, PhD
Advancing Colposcopy Training and Education in Cervical Cancer Prevention
Speaker: Syamel Muhammad, MD, PhD
Improving Access to Diagnosis and Management of Preinvasive Cervical Lesions in Peripheral Areas
Speaker: Heru Priyanto, MD, PhD
Could HPV Primary Screening Be the Way Forward for Indonesia’s Archipelago Geography?
Speaker: Andi Darma Putra, MD, PhD
Exploring the Possibility and Acceptability of Self-Sampling for Cervical Cancer Screening in Indonesia
Speaker: Fitriyadi Kusuma, MD, PhD
The Screening and Treatment of Cervical Cancers and other HPV-Related Diseases in Latin America
Moderator: Carmen Irela Troya de Soto, MD
|